Muscle Injury: In rat muscle transection and crush injury models, BPC-157 treatment improved muscle structure, function, and biomechanics, including improved load to failure, motor function indices, and reduced atrophy
BPC-157 is not designated for medical, diagnostic, or therapeutic applications
Further, NASO B12 was well-tolerated throughout the treatment period.[] Patients on metformin therapy receiving NASO B12 should also be instructed that they will require weekly intranasal administration of NASO B12 spray in each nostril after correction of vitamin B12 deficiency for the remainder of their lives
International Journal of Peptide Research and Therapeutics , 29 (4)
Research Use Disclaimer Bpc-157 Pre-Mixed Peptide from Stackpure is supplied strictly for in vitro research and laboratory purposes
Slowed Gastric Emptying These medications decelerate stomach-to-intestine transitions, prolonging fullness and curbing post-meal blood sugar spikes
